Business Context and Reporting Period
This Form 8-K filing by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) covers the period ending November 17, 2006. The report addresses significant corporate governance changes regarding the departure of the company's top executive leadership.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive personnel changes and does not contain financial performance data.
Material Changes
- Executive Resignation: J. Raymond Elliott, Chairman of the Board, President, and Chief Executive Officer, notified the Board on November 17, 2006, of his intent to resign as President and CEO in the first half of 2007.
- Role Transition: Mr. Elliott will remain as Chairman of the Board following his resignation from operational leadership roles.
- Employment Agreement: A new employment agreement was executed on November 18, 2006, effective upon his resignation as CEO and continuing through November 30, 2007.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or specific risk factors related to operations. The primary contingency noted is the leadership transition scheduled for the first half of 2007. A press release issued on November 20, 2006, provides further details on this development.
Investor Verification Checklist
- Verify the exact date of J. Raymond Elliott's resignation as President and CEO.
- Review the terms of the employment agreement (Exhibit 10.1) regarding compensation and duration through November 2007.
- Confirm the identity of the successor President and CEO to be appointed in the first half of 2007.
- Check subsequent filings for the official announcement of the leadership transition.